By: Caroline Seymour From: onclive.com The utility of circulating tumor DNA (ctDNA) continues to unfold in breast cancer, explained Joyce A. O’Shaughnessy, MD—citing the first results of the plasmaMATCH trial as the most recent demonstration of precision medicine in the field. In the trial, approximately 1000 patients with metastatic breast cancer underwent ctDNA testing. Patients were grouped into 1 of …
-
-
The True Meaning of Easter
-
Peace for a Breast Cancer Survivor
-
What Would Motivate a Person to Action After a Breast Cancer Diagnosis
-
What’s on the Outside Doesn’t Really Matter to Many Breast Cancer Survivors
-
From a Breast Cancer Survivor: A Message to Telephone and Telemarketer Solicitors
